|
Delayed
Liquidnet
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-0.40% | - |
| Aug. 24 | FTSE 100 outperforms as oil price heads lower | AN |
| Aug. 24 | European Stocks Close Mostly Lower in Monday Trading; US Treasury Secretary Scott Bessent to Give Details on Iran Sanctions | MT |
| Market Cap | 75.75B 103B 88.52B 82.83B 143B 9,884B 144B 980B 381B 4,964B 387B 379B 16,422B | P/E 2026 * |
14.3x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 95.59B 130B 112B 105B 180B 12,472B 182B 1,237B 481B 6,264B 489B 479B 20,723B | EV / Sales 2026 * |
2.82x | EV / Sales 2027 * | 2.61x |
| Free-Float |
92.75% | Yield 2026 * |
3.68% | Yield 2027 * | 3.96% |
Last Transcript: GlaxoSmithKline plc
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
James Ford
CMP | Compliance Officer | - | 2018-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 67 | 2019-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -0.40% | - | - | 105B | |
| -0.67% | +5.66% | +75.21% | +125.34% | 1,119B | |
| +1.04% | +4.87% | +52.29% | +65.95% | 651B | |
| -0.17% | +6.04% | +25.60% | +79.85% | 468B | |
| -1.38% | +4.31% | +41.64% | +41.08% | 374B | |
| -0.52% | +3.53% | +24.32% | +40.27% | 302B | |
| -1.06% | +5.67% | +1.19% | +12.44% | 259B | |
| +1.03% | +6.90% | +51.11% | +72.46% | 238B | |
| -0.53% | +1.54% | -17.77% | -54.10% | 208B | |
| +0.42% | +6.06% | +27.86% | +90.47% | 181B | |
| Average | -0.23% | +5.17% | +31.27% | +52.64% | 422.21B | |
| Weighted average by Cap. | -0.25% | +5.40% | +43.93% | +72.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.94B 46.27B 39.66B 37.11B 64.03B 4,428B 64.69B 439B 171B 2,224B 174B 170B 7,357B | 35.52B 48.42B 41.5B 38.84B 67.01B 4,634B 67.7B 459B 179B 2,327B 182B 178B 7,699B |
| Net income | 5.44B 7.41B 6.35B 5.94B 10.26B 709B 10.36B 70.32B 27.33B 356B 27.79B 27.22B 1,178B | 6.48B 8.84B 7.58B 7.09B 12.23B 846B 12.36B 83.89B 32.6B 425B 33.16B 32.47B 1,406B |
| Net Debt | 19.84B 27.05B 23.18B 21.69B 37.43B 2,588B 37.82B 257B 99.74B 1,300B 101B 99.34B 4,301B | 17.06B 23.26B 19.94B 18.65B 32.19B 2,226B 32.52B 221B 85.77B 1,118B 87.23B 85.43B 3,698B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
